These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30583247)

  • 21. Benznidazole Nanoformulates: A Chance to Improve Therapeutics for Chagas Disease.
    Vinuesa T; Herráez R; Oliver L; Elizondo E; Acarregui A; Esquisabel A; Pedraz JL; Ventosa N; Veciana J; Viñas M
    Am J Trop Med Hyg; 2017 Nov; 97(5):1469-1476. PubMed ID: 29016287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current advances in drug discovery for Chagas disease.
    Scarim CB; Jornada DH; Chelucci RC; de Almeida L; Dos Santos JL; Chung MC
    Eur J Med Chem; 2018 Jul; 155():824-838. PubMed ID: 30033393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.
    Nogueira Silva JJ; Pavanelli WR; Gutierrez FR; Alves Lima FC; Ferreira da Silva AB; Santana Silva J; Wagner Franco D
    J Med Chem; 2008 Jul; 51(14):4104-14. PubMed ID: 18570370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo and in vitro auranofin activity against Trypanosoma cruzi: Possible new uses for an old drug.
    da Silva MT; Silva-Jardim I; Portapilla GB; de Lima GM; Costa FC; Anibal Fde F; Thiemann OH
    Exp Parasitol; 2016 Jul; 166():189-93. PubMed ID: 26183422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
    Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
    Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
    Zanusso Junior G; Massago M; Kian D; Toledo MJO
    Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
    Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW
    Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease.
    Jones K; Versteeg L; Damania A; Keegan B; Kendricks A; Pollet J; Cruz-Chan JV; Gusovsky F; Hotez PJ; Bottazzi ME
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29311242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
    Beltran-Hortelano I; Perez-Silanes S; Galiano S
    Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
    Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.
    Moreno-Viguri E; Jiménez-Montes C; Martín-Escolano R; Santivañez-Veliz M; Martin-Montes A; Azqueta A; Jimenez-Lopez M; Zamora Ledesma S; Cirauqui N; López de Ceráin A; Marín C; Sánchez-Moreno M; Pérez-Silanes S
    J Med Chem; 2016 Dec; 59(24):10929-10945. PubMed ID: 28002965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.
    Khare S; Liu X; Stinson M; Rivera I; Groessl T; Tuntland T; Yeh V; Wen B; Molteni V; Glynne R; Supek F
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6385-94. PubMed ID: 26239982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
    Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
    Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole.
    Honorato SB; Mendonça JS; Boechat N; Oliveira AC; Mendes Filho J; Ellena J; Ayala AP
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():389-94. PubMed ID: 24076454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas Disease.
    de Mello CG; Branquinho RT; Oliveira MT; Milagre MM; Saúde-Guimarães DA; Mosqueira VC; Lana Md
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5215-22. PubMed ID: 27324760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitrotriazole-Based Compounds as Antichagasic Agents in a Long-Treatment
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Mazzeti AL; Gonçalves KR; Mendes PF; Bahia MT
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
    Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different Therapeutic Outcomes of Benznidazole and VNI Treatments in Different Genders in Mouse Experimental Models of Trypanosoma cruzi Infection.
    Guedes-da-Silva FH; Batista DG; da Silva CF; Meuser MB; Simões-Silva MR; de Araújo JS; Ferreira CG; Moreira OC; Britto C; Lepesheva GI; Soeiro Mde N
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7564-70. PubMed ID: 26416857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental study on the therapeutic action of Ro 7-1051 on infections caused by different strains of Trypanosoma cruzi].
    Andrade SG; Figueira RM
    Rev Inst Med Trop Sao Paulo; 1977; 19(5):335-41. PubMed ID: 416483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.